Detalhe da pesquisa
1.
Impact of the Route and Schedule of Immunization on the Serological and Virological Response of Chronic Hepatitis B Patients Treated with HeberNasvac.
Euroasian J Hepatogastroenterol
; 13(2): 73-78, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38222949
2.
HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure Prophylaxis.
Euroasian J Hepatogastroenterol
; 11(2): 59-70, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34786358
3.
Immunization with a DNA vaccine candidate in chronic hepatitis C patients is safe, well tolerated and does not impair immune response induction after anti-hepatitis B vaccination.
J Gene Med
; 12(1): 107-16, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19866482
4.
Five-year Follow-up of Chronic Hepatitis B Patients Immunized by Nasal Route with the Therapeutic Vaccine HeberNasvac.
Euroasian J Hepatogastroenterol
; 8(2): 133-139, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30828555
5.
Impacto del programa de inmunización anti-virus de hepatitis B (VHB) en pacientes sometidos a diálisis en la Habana, Cuba / Impact of the anti-hepatitis B immunization program in patients submitted to dialysis in the Habana, Cuba
Invest. clín
; 41(4): 237-44, dic. 2000. tab, graf
Artigo
em Espanhol
| LILACS | ID: lil-294296